Address
1 Avenue d'Ester - 87280 LIMOGES
Email
info@curlim.eu
🇩🇪 Next stop: BIO-Europe 2026 in Cologne!
From November 9–11, CURLIM will be joining the global biopharma community at BIO-Europe 2026, one of Europe’s key meeting points for biotech leaders, pharma companies, investors and partners.
As we continue to advance CLM001, our lead nanomedicine candidate for Charcot-Marie-Tooth disease type 1A (CMT1A), BIO-Europe will be a key opportunity to share our latest progress and discuss the next steps of our program.
Over three days, our team will be meeting with European pharma companies, investors and potential strategic partners to explore new opportunities and build connections that can help move our project forward.